A Study of GC203 TIL in PDCA (RJ)

Clinical trial NCT06828328 · RECRUITING

Trial details

NCT number: NCT06828328
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Pancratic Ductal Adenocarcinoma Treatment Side Effects Tumor Infiltrating Lymphocytes

Start date: 2025-02-10
Primary completion: 2028-01-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.